COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Posted by Written by Reading Time: 13 minutes

(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on April 18, 2021)

Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.

Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.

For specific updates concerning China and related business advisory, please click here.

ASEAN coronavirus updates (Live updates by country)

Brunei

Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.   

  • Brunei saw two new cases on April 14, taking the total to 221 amid three deaths.
  • Three new cases reported on April 9, taking the total to 219 amid three deaths.
  • Brunei saw one new case on April 8, bringing the total to 216 cases amid three deaths.

Cambodia

Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.  

  • Cambodia reported 624 new cases and two deaths on April 19, taking the tallies to 7,013 cases and 45 deaths.
  • Cambodia recorded 618 new cases and four deaths on April 18, bringing the totals to 6,389 cases and 43 deaths.
  • Cambodia saw 291 new cases and one death on April 17, taking the tallies to 5,771 cases and 39 deaths.

Indonesia

Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 268 million and price sensitivity at Sinovac’s estimated costs at 200,000 rupiah (US$20) a dose. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population.  Australia has stated it will also provide financial support to solve these issues.  

  • Indonesia reported 4,952 new cases and 143 deaths on April 19, bringing the totals to 1,609,300 cases and 43,567 deaths.
  • Indonesia recorded 4,585 new cases and 96 deaths on April 18, taking the tallies to 1,604,348 cases and 43,424 deaths.
  • Indonesia saw 5,041 new cases and 132 deaths on April 17, taking the totals to 1,599,763 cases and 43,328 deaths.

Laos

Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.  

  • Laos reported four new cases on April 17, taking the total to 58.
  • Laos reported one new case on April 16, taking the total to 54.
  • Laos saw one new case on April 14, taking the total to 53.

Malaysia

Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens. 

  • Malaysia reported 2,078 new cases and eight deaths on April 19, bringing the totals to 377,132 cases and 1,386 deaths.
  • Malaysia saw 2,195 new cases and eight deaths on April 18, taking the tallies to 375,054 cases and 1,378 deaths.
  • Malaysia reported 2,331 new cases and five deaths on April 17, bringing the totals to 372,859 cases and 1,370 deaths.

Myanmar

Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.   

  • Myanmar recorded nine new cases on April 18, taking the total to 142,628 amid 3,206 deaths.
  • The country saw two new cases on April 17, bringing the total to 142,619 amid 3,206 deaths.
  • Myanmar recorded seven new cases on April 16, taking the total to 142,617 amid 3,206 deaths.

Philippines

The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees. 

  • The Philippines saw 9,628 new cases and 88 deaths on April 19, taking the totals to 945,745 cases and 16,048 deaths.
  • The Philippines recorded 10,098 new cases and 150 deaths on April 18, bringing the tallies to 936,133 cases and 15,960 deaths.
  • The Philippines saw 11,101 new cases and 72 deaths on April 17, taking the totals to 926,052 cases and 15,810 deaths.

Singapore

Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.     

  • Singapore reported 20 new cases on April 19, taking the total to 60,851 cases amid 30 deaths.
  • Singapore saw 23 new cases on April 18, bringing the total to 60,831 cases amid 30 deaths.
  • Singapore saw 39 new cases on April 17, taking the total to 60,808 cases amid 30 deaths.

Thailand

Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.   

  • Thailand reported 1,390 new cases and three deaths on April 19, taking the totals to 43,742 cases and 104 deaths
  • Thailand saw 1,767 new cases and two deaths on April 18, bringing the totals to 42,352 cases and 101 deaths.
  • Thailand reported 1,547 new cases and two deaths on April 17, taking the tallies to 40,585 cases and 99 deaths.

Vietnam

Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.  

Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.

  • As of April 19, 2021, Vietnam’s Ministry of Health confirmed a total of 2,785 cases of COVID-19. However, 2,475 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 35 deaths due to the pandemic. The latest cases were all imported and quarantined on arrival.
  • The country saw nine new cases on April 17, taking the total to 2,781 cases amid 35 deaths.
  • As of April 16, 2021, Vietnam’s Ministry of Health confirmed a total of 2,772 cases of COVID-19. However, 2,445 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 35 deaths due to the pandemic. The latest cases were all imported and quarantined on arrival.

Other Asian countries and Regions

Afghanistan

Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani’s from obtaining treatment of either. 

  • Afghanistan has 57,898 cases and 2,546 deaths as of April 18.
  • Afghanistan has 57,793 cases and 2,540 deaths as of April 17.
  • Afghanistan has 57,721 cases and 2,539 deaths as of April 16.

Bangladesh

Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.     

  • As of April 18, Bangladesh has 718,950 cases and 10,385 deaths.
  • Bangladesh has 715,252 cases and 10,283 deaths as of April 17.
  • Bangladesh has 711,779 cases and 10,182 deaths as of April 16.

Bahrain

Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.  

  • Bahrain has 164,110 cases and 594 deaths as of April 18.
  • Bahrain has 163,113 cases and 588 deaths as of April 17.
  • As of April 16, Bahrain has 162,089 cases and 581 deaths.

China

For specific updates concerning China, please click here.

For a complete overview of China’s vaccine availability please go here.

  • China recorded 11 new cases on April 19, bringing the total to 90,510.
  • China reported 16 new cases on April 18, taking the total to 90,499.
  • China saw 15 new cases on April 17, taking the total to 90,483.

East Timor

East Timor is receiving assistance from the Gavi Institute.  

  • East Timor has 1,306 cases and two deaths as of April 18.
  • As of April 17, East Timor has 1,236 cases and two deaths.
  • East Timor has 1,193 cases and two deaths as of April 16.

Hong Kong

Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.  

  • Hong Kong has 11,684 cases and 209 deaths as of April 18.
  • Hong Kong has 11,654 cases and 209 deaths as of April 17.
  • Hong Kong has 11,636 cases and 209 deaths as of April 16.

India

For a complete overview of India’s vaccine availability please go here.

  • India has 15,057,767 cases and 178,793 deaths as of April 18.
  • As of April 17, India has 14,782,461 cases and 177,168 deaths.
  • Our new India-specific updates can be found here.

Iran

Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.   

  • As of April 18, Iran has 2,237,089 cases and 66,732 deaths.
  • Iran has 2,215,445 cases and 66,327 deaths as of April 17.
  • Iran has 2,194,133 cases and 66,008 deaths as of April 16.

Iraq

Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021. 

  • Iraq has 977,175 cases and 14,981 deaths as of April 18.
  • As of April 17, Iraq has 970,987 cases and 14,948 deaths.
  • As of April 16, Iraq has 964,435 cases and 14,915 deaths.

Japan

Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021. 

  • Japan has 529,829 cases and 9,622 deaths as of April 18.
  • Japan has 525,218 cases and 9,584 deaths as of April 17.
  • As of April 16, Japan has 520,745 cases and 9,538 deaths.

Jordan

Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021. 

  • Jordan has 685,973 cases and 8,246 deaths as of April 18.
  • Jordan has 683,466 cases and 8,178 deaths as of April 17.
  • As of April 16, Jordan has 681,870 cases and 8,117 deaths.

Kazakhstan

Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.  

  • As of April 18, Kazakhstan has 287,001 cases and 3,384 deaths.
  • Kazakhstan has 284,173 cases and 3,364 deaths as of April 17.
  • Kazakhstan has 281,351 cases and 3,333 deaths as of April 16.

Kuwait

All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.

  • Kuwait has 256,987 cases and 1,448 deaths as of April 18.
  • Kuwait has 255,860 cases and 1,440 deaths as of April 17.
  • Kuwait has 254,472 cases and 1,436 deaths as of April 16.

Kyrgyzstan

Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021. 

  • Kyrgyzstan has 91,883 cases and 1,549 deaths as of April 18.
  • Kyrgyzstan has 91,639 cases and 1,546 deaths as of April 17.
  • Kyrgyzstan has 91,374 cases and 1,544 deaths as of April 16.

Lebanon

Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.  

  • Lebanon has 510,403 cases and 6,925 deaths as of April 18.
  • Lebanon has 508,503 cases and 6,886 deaths as of April 17.
  • As of April 16, Lebanon has 506,808 cases and 6,854 deaths.

Macao

Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.   

  • Macao has 48 cases as of February 5.
  • The number of cases has reached 45 as of July 24.
  • Macao records a single infection, bringing the total to 43.

Maldives

The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.  

  • The Maldives has 26,348 cases and 70 deaths as of April 18.
  • The Maldives has 26,145 cases and 69 deaths as of April 17.
  • As of April 16, the Maldives has 26,021 cases and 68 deaths.

Mongolia

Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021. 

  • As of April 18, Mongolia has 21,995 cases and 44 deaths.
  • Mongolia has 20,655 cases and 41 deaths as of April 17.
  • Mongolia has 19,672 cases and 37 deaths as of April 16.

Nepal

Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.  

  • Nepal has 284,673 cases and 3,083 deaths as of April 18.
  • Nepal has 283,658 cases and 3,075 deaths as of April 17.
  • Nepal has 282,890 cases and 3,070 deaths as of April 16.

North Korea

North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.  

  • North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.

Oman

Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).    

  • Oman has 180,031 cases and 1,878 deaths as of April 18.
  • Oman has 176,668 cases and 1,821 deaths as of April 15.
  • As of April 14, Oman has 175,633 cases and 1,807 deaths.

Pakistan

Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021. 

  • As of April 18, Pakistan has 756,285 cases and 16,243 deaths.
  • Pakistan has 750,158 cases and 16,094 deaths as of April 17.
  • Pakistan has 745,182 cases and 15,982 deaths as of April 16.

Palestine

Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.   

  • Palestine has 280,741 cases and 3,017 deaths as of April 18.
  • Palestine has 279,753 cases and 2,983 deaths as of April 17.
  • As of April 16, Palestine has 278,135 cases and 2,955 deaths.

Qatar

Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021. 

  • As of April 18, Qatar has 977,175 cases and 14,981 deaths.
  • Qatar has 195,757 cases and 376 deaths as of April 17.
  • Qatar has 194,930 cases and 367 deaths as of April 16.

Russia

A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.

  • As of April 18, Russia has 4,702,101 cases and 105,582 deaths.
  • Russia has 4,693,469 cases and 105,193 deaths as of April 17.
  • Our new Russia-specific updates here.

Saudi Arabia

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021. 

  • As of April 18, Saudi Arabia has 404,970 cases and 6,823 deaths.
  • Saudi Arabia has 404,054 cases and 6,810 deaths as of April 17.
  • Saudi Arabia has 403,106 cases and 6,801 deaths as of April 16.

South Korea

South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021. 

  • Sout Korea has 114,646 cases and 1,801 deaths as of April 19.
  • South Korea has 114,115 cases and 1,797 deaths as of April 18.
  • As of April 17, South Korea has 113,444 cases and 1,794 deaths.

Sri Lanka

Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.    

  • Sri Lanka has 96,796 cases and 618 cases as of April 18.
  • Sri Lanka has 96,354 cases and 617 deaths as of April 17.
  • As of April 16, Sri Lanka has 96,186 cases and 615 deaths.

Taiwan

Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.  

  • As of April 18, Taiwan has 1,073 cases and 11 deaths.
  • Taiwan has 1,072 cases and 11 deaths as of April 17.
  • Taiwan has 1,070 cases and 11 deaths as of April 16.

Turkey

Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.   

  • Turkey has 4,268,447 cases and 35,926 deaths as of April 18.
  • Turkey has 4,212,645 cases and 35,608 deaths as of April 17.
  • As of April 16, Turkey has 4,150,039 cases and 35,320 deaths.

United Arab Emirates

The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates.  The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.  

  • The UAE has 497,154 cases and 1,554 deaths as of April 18.
  • The UAE has 495,224 cases and 1,550 deaths as of April 17.
  • The UAE has 493,266 cases and 1,547 deaths as of April 16.

Uzbekistan

Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021. 

  • Uzbekistan has 86,680 cases and 638 deaths as of April 18.
  • Uzbekistan has 86,338 cases and 636 deaths as of April 17.
  • Uzbekistan has 86,022 cases and 635 deaths as of April 16.

Yemen

Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.   

  • Yemen has 5,812 cases and 1,126 deaths as of April 18.
  • Yemen has 5,770 cases and 1,119 deaths as of April 17.
  • Yemen has 5,715 cases and 1,108 deaths as of April 16.

Related Reading


About Us

ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in SingaporeHanoiHo Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at asia@dezshira.com or visit our website at www.dezshira.com.